Braves Face Pitching Setback as Schwellenbach and Waldrep Prepare for Surgery
NORTH PORT, Fla. – The Atlanta Braves are bracing for a challenging start to the 2026 Major League Baseball season, as right-handed pitchers Spencer Schwellenbach and Hurston Waldrep are both scheduled to undergo elbow surgery. The injuries represent a significant blow to the team’s pitching rotation, raising questions about their depth and potential performance in the early months of the season. While the Braves are not providing a definitive timeline for the return of either player, both are expected to miss at least the first two months of the regular season, being placed on the 60-day injured list.
The news comes as a disappointment for a Braves team that had high hopes for both young arms. Schwellenbach, 25, underwent surgery on Wednesday to address “loose bodies” in his elbow, according to Braves manager Walt Weiss. Waldrep, a highly touted prospect, is scheduled for a similar procedure next week. Despite the setbacks, Weiss expressed optimism that both pitchers will be able to contribute at some point during the 2026 season, though he acknowledged the uncertainty inherent in such situations. “I’m not sure,” Weiss said, as reported by MLB.com. “We all hope for that. But you never know how these things head.”
Schwellenbach’s Road to Recovery
Schwellenbach’s injury woes began earlier this year, with elbow tightness surfacing during a bullpen session on January 30th, as detailed in reports from MLB.com. This latest surgery addresses a more complex issue – the removal of bone spurs – potentially extending his recovery period compared to Waldrep. Prior to the setback, Schwellenbach was considered a potential top-three starter for the Braves this season. In 2025, he posted a 7-4 record with a 3.08 ERA in 17 starts before a fractured right elbow sidelined him for the final three months of the season. His Major League debut came in 2024, where he finished with an 8-7 record and a 3.35 ERA across 21 starts. MLB.com provides further details on his injury history.
Waldrep’s Procedure and Potential Impact
Waldrep’s surgery will focus on removing loose bodies – cartilage or bone chips – from his elbow, a procedure generally requiring a shorter recovery time than bone spur removal. The 23-year-old right-hander was a first-round pick for the Braves in the 2023 draft and had been generating excitement during spring training. He showcased impressive velocity, hitting 99 mph during a live batting practice session on February 12th, according to MLB.com. While Waldrep may have been initially targeted for Triple-A due to the Braves’ crowded rotation, expectations remained high for his potential impact. In 10 appearances (nine starts) last season, he maintained a 2.88 ERA.
Braves’ Pitching Depth Tested
The injuries to Schwellenbach and Waldrep exacerbate an existing concern for the Braves – pitching depth. The team already saw six different starting pitchers miss at least six weeks of action in 2025, highlighting a pattern of pitching injuries. This latest development leaves the Braves searching for solutions as they approach the start of the season. As noted by ESPN, the team has yet to add a starting pitcher despite calls from fans to bolster the rotation since November. ESPN reports on the team’s ongoing search for pitching reinforcements.
The situation is particularly challenging given the Braves’ aspirations for a deep postseason run. A reliable starting rotation is crucial for success in October, and the absence of two promising young pitchers will undoubtedly test the team’s resilience and depth. The Braves will need to rely on their remaining starting pitchers and potentially explore trade options to address the void left by Schwellenbach and Waldrep.
Looking Ahead: Recovery and Team Strategy
The Braves are proceeding cautiously with both pitchers, prioritizing their long-term health over a rushed return to the mound. While the team hopes to see both Schwellenbach and Waldrep back in action this season, they are not setting any firm timelines. The recovery process will be closely monitored, and the pitchers will be gradually eased back into throwing as they progress. The team’s medical staff will play a critical role in determining when each pitcher is ready to resume competitive pitching.
The absence of Schwellenbach and Waldrep will likely lead to opportunities for other pitchers within the organization. Players currently in the minor leagues or on the fringes of the major league roster may receive increased opportunities to prove their worth. The Braves will be evaluating these pitchers closely to identify potential replacements for the injured starters. The team’s ability to identify and develop these replacements will be crucial to their success in the coming months.
The Braves’ situation underscores the inherent risks associated with baseball, particularly the vulnerability of pitchers to arm injuries. The team’s medical staff is constantly working to prevent injuries and optimize the health of their pitchers, but setbacks are inevitable. The Braves will need to navigate this challenge with patience, resilience, and a commitment to developing their pitching depth.
The Atlanta Braves will begin the 2026 season without two key members of their pitching staff, a situation that presents a significant challenge. However, the team remains optimistic that both Spencer Schwellenbach and Hurston Waldrep will be able to return to the mound later in the season. The Braves’ success will depend on their ability to overcome this adversity and locate ways to strengthen their pitching rotation. Updates on the pitchers’ recovery will be provided as they become available. Fans can follow the Braves’ progress throughout the season on the team’s official website and social media channels.
The next update regarding the pitchers’ recovery is expected following their initial post-operative evaluations, scheduled for approximately two weeks after their respective surgeries. Fans are encouraged to share their thoughts and support for the Braves pitchers in the comments section below.